Concepedia

Alan F. Wahl

AF

Statistics

Publications

49

Citations

8.2K

H-Index

36

Active since

1983

Affiliations

Seagen (United States)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

Stanford University

University of Rochester

Alan F. Wahl is an author at Seagen (United States) specializing in life sciences, oncology, and molecular biology.

Publications per year

1983–2019

49

Publications

49

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Svetlana O. Doronina, Brian E. Toki, Michael Torgov et al. · Nature Biotechnology · 2003 · 1.2K citations

, , +14

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer et al. · Blood · 2003 · 921 citations

, , +11

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

Alan F. Wahl, Karen Donaldson, Craig Faircnild et al. · Nature Medicine · 1996 · 662 citations

, , +14

Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery:  Effects of Linker Technology on Efficacy and Toxicity

Svetlana O. Doronina, Brian A. Mendelsohn, Tim D. Bovee et al. · Bioconjugate Chemistry · 2005 · 512 citations

, , +17

Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

Andrew McShea, Peggy L.R. Harris, Kevin R. Webster et al. · PubMed · 1997 · 431 citations

, , +14

1–5 of 49